Search clinical trials for: Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL), Venetoclax,
Total 23777 results
-
Fudan UniversityCompleted
-
OriCell Therapeutics Co., Ltd.RecruitingCardiovascular Diseases | Vascular Diseases | Neoplasms | Immune System Diseases | Neoplasms by Histologic Type | Lymphoproliferative Disorders | Immunoproliferative Disorders | Hematologic Diseases | Hemostatic Disorders | Hemorrhagic Disorders | Multiple Myeloma | Neoplasms, Plasma Cell | Paraproteinemias | Blood...United States
-
ImmPACT BioRecruitingRefractory Non-Hodgkin Lymphoma | Relapsed Non-Hodgkin LymphomaUnited States
-
Ruijin HospitalUnknownDiffuse Large B-cell Lymphoma | Follicular Lymphoma Grade 3BChina
-
Novartis PharmaceuticalsCompletedDiffuse Large B-cell LymphomaAustria, Canada, United States
-
Planexta, IncPharmaxi LLCCompleted
-
Ruijin HospitalNot yet recruitingDiffuse Large B Cell Lymphoma
-
CelgeneCompletedDiffuse B-Cell LymphomaCanada, Spain, Belgium, United States
-
Biocon LimitedProfil Institut für Stoffwechselforschung GmbHCompletedHealthy VolunteerGermany
-
The First Affiliated Hospital with Nanjing Medical...UnknownDiffuse Large B Cell LymphomaChina
-
National Taiwan University HospitalActive, not recruitingCongenital Heart Disease | PediatricTaiwan
-
First Affiliated Hospital of Zhejiang UniversityCSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.RecruitingMyeloid Malignancy | Relapsed/Refractory Acute Myeloid LeukaemiaChina
-
MorphoSys AGActive, not recruitingDiffuse Large B Cell LymphomaSpain, Czechia, Korea, Republic of, Israel, Poland, Italy, Austria, France, United States
-
Royal Marsden NHS Foundation TrustHoffmann-La RocheTerminatedB-cell Lymphoma | Non-Hodgkin's LymphomaUnited Kingdom
-
Peter MacCallum Cancer Centre, AustraliaHoffmann-La RocheActive, not recruitingDiffuse Large B Cell Lymphoma | High-grade B-cell LymphomaAustralia
-
Denovo Biopharma LLCCompletedDiffuse Large B-Cell LymphomaUnited States, China
-
CTI BioPharmaCompletedDiffuse Large-Cell LymphomaUnited States, Germany, Canada, Italy, France
-
Austin HealthMerck KGaA, Darmstadt, GermanyActive, not recruitingLymphomas Non-Hodgkin's B-CellAustralia
-
Rush University Medical CenterTerminatedDiffuse Large B-Cell LymphomaUnited States
-
Pharmacyclics LLC.Celgene CorporationCompletedDiffuse Large B Cell Lymphoma Refractory | Diffuse Large B Cell Lymphoma RelapsedUnited States
-
MinaPharm PharmaceuticalsUnknownr-Hirudin (Thrombexx) Efficacy in Treatment of HaematomasEgypt
-
Beijing Tongren HospitalRecruitingT-lymphoblastic Lymphoma | Natural Killer/T-Cell Lymphoma, Nasal and Nasal-TypeChina
-
Shandong Provincial HospitalRecruitingMantle Cell Lymphoma | Diffuse Large B-cell Lymphoma | High Grade B-Cell Lymphoma, Not Otherwise Specified | High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 Rearrangements | B-cell NonHodgkin LymphomaChina
-
University Hospital Southampton NHS Foundation...CompletedNon Hodgkin LymphomaUnited Kingdom
-
University of California, Los AngelesNational Institute of Allergy and Infectious Diseases (NIAID)CompletedRespiratory Tract Infections | Influenza | VaccinesUnited States
-
Huazhong University of Science and TechnologyRecruitingDiffuse Large B Cell LymphomaChina
-
GWT-TUD GmbHHoffmann-La RocheRecruitingRefractory Diffuse Large B-Cell Lymphoma | Relapsed Diffuse Large B-cell LymphomaGermany, Spain, United Kingdom, Austria
-
CTI BioPharmaCompletedDiffuse Large B-cell Lymphoma | de Novo DLBCL | DLBCL Transformed From Indolent Lymphoma | Follicular Grade 3 LymphomaUnited States, Germany, Italy, United Kingdom, Hungary, France, Spain, Ukraine, Czechia, Austria, Belgium, Bulgaria, Denmark, Poland, Romania, Russian Federation, Slovakia
-
Grupo Español de Linfomas y Transplante Autólogo...Completed
-
The Lymphoma Academic Research OrganisationCompletedLymphoma | Diffuse Large B-cell LymphomaBelgium, Switzerland, France, Australia, Spain, Israel, Austria, Portugal, Poland
-
LLS PedAL Initiative, LLCKura OncologyNot yet recruitingRelapsed/Refractory KMT2A-r Acute Leukemia | Relapsed/Refractory NUP98-r Acute Leukemia | Relapsed/Refractory NPM1-m Acute Leukemia
-
Xencor, Inc.TerminatedDiffuse Large-cell B-cell LymphomaSpain, United States, France
-
St. Joseph's Hospital and Medical Center, PhoenixTerminatedGlioblastomaUnited States
-
PfizerEMD SeronoTerminatedDiffuse Large B-Cell LymphomaUnited States, Belgium, United Kingdom, Spain, Australia, Korea, Republic of, Italy, Poland
-
Kosin University Gospel HospitalCompletedDiffuse Large B Cell LymphomaKorea, Republic of
-
Zhejiang DTRM BiopharmaRecruitingFollicular Lymphoma | Diffuse Large B Cell Lymphoma | Refractory Chronic Lymphocytic Leukemia | Richter's Transformation | Relapsed Chronic Lymphocytic LeukemiaUnited States
-
Klinikum NürnbergUnknown
-
The Lymphoma Academic Research OrganisationTerminated
-
Yang ZhangTCRCure Biopharma Ltd.Recruiting
-
The First Affiliated Hospital of Xiamen UniversityShanxi Province Cancer Hospital; Sun Yat-sen University; Jiangsu Provincial People... and other collaboratorsRecruiting
-
Second Affiliated Hospital, School of Medicine,...Ningbo Medical Center Lihuili Hospital; Huizhou Municipal Central Hospital; Taizhou... and other collaboratorsRecruitingDiffuse Large B-cell LymphomaChina
-
Niyayesh ClinicTehran University of Medical SciencesCompletedRefractory MigraineIran, Islamic Republic of
-
Zhao WeiliNot yet recruitingDiffuse Large B-cell LymphomaChina
-
Fudan UniversityRecruitingDiffuse Large B-cell LymphomaChina
-
Jiangsu HengRui Medicine Co., Ltd.SuspendedNeoplasms by Histologic Type | Lymphoma | Hematologic Neoplasms | Advanced Cancer | Immunotherapy | Physiological Effects of DrugsChina
-
Guangdong Ruishun Biotech Co., LtdFirst Affiliated Hospital of Zhejiang UniversityRecruiting
-
The First Affiliated Hospital of Soochow UniversityRecruitingDiffuse Large B-Cell LymphomaChina
-
Fondazione Italiana Linfomi ONLUSActive, not recruitingRelapsed T-Cell Lymphoma | Refractory T-Cell LymphomaItaly
-
AbbVieRoche-GenentechActive, not recruitingMultiple MyelomaUnited States, Australia, Canada, China, Czechia, Denmark, France, Germany, Greece, Israel, Italy, Japan, Korea, Republic of, Russian Federation, Singapore, Spain, Sweden, Turkey, Ukraine, United Kingdom